Korean Manufacturer Warned for GMP, Quality Violations

Drug Industry Daily
A A
The FDA issued a warning to a Korean drugmaker for significant current good manufacturing practice violations and the lack of an adequate quality control unit.

To View This Article:

Login

Subscribe To Drug Industry Daily